Your browser doesn't support javascript.
loading
Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study.
Zhukovsky, Christina; Sandgren, Sofia; Silfverberg, Thomas; Einarsdottir, Sigrun; Tolf, Andreas; Landtblom, Anne-Marie; Novakova, Lenka; Axelsson, Markus; Malmestrom, Clas; Cherif, Honar; Carlson, Kristina; Lycke, Jan; Burman, Joachim.
Affiliation
  • Zhukovsky C; Department of Neuroscience, Uppsala University, Uppsala, Sweden.
  • Sandgren S; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, Gothenburg, Sweden.
  • Silfverberg T; Department of of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Einarsdottir S; Center for Clinical Research Dalarna, Uppsala University, Uppsala, Sweden.
  • Tolf A; Department of Hematology and Coagulation, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Landtblom AM; Department of Neuroscience, Uppsala University, Uppsala, Sweden.
  • Novakova L; Department of Neuroscience, Uppsala University, Uppsala, Sweden.
  • Axelsson M; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, Gothenburg, Sweden.
  • Malmestrom C; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, Gothenburg, Sweden.
  • Cherif H; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, Gothenburg, Sweden.
  • Carlson K; Department of of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Lycke J; Department of of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Burman J; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, Gothenburg, Sweden.
J Neurol Neurosurg Psychiatry ; 92(2): 189-194, 2021 02.
Article in En | MEDLINE | ID: mdl-33106366

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuroprotective Agents / Hematopoietic Stem Cell Transplantation / Multiple Sclerosis, Relapsing-Remitting / Alemtuzumab Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: J Neurol Neurosurg Psychiatry Year: 2021 Document type: Article Affiliation country: Suecia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuroprotective Agents / Hematopoietic Stem Cell Transplantation / Multiple Sclerosis, Relapsing-Remitting / Alemtuzumab Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: J Neurol Neurosurg Psychiatry Year: 2021 Document type: Article Affiliation country: Suecia